Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for David Morgan

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    ECOGHEME4412

    08/18/2016

    A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma

    Treatment

    VICCHEM1402

    09/15/2014

    A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Lenalidomide, with and without Rituximab in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma


    Print this page for your doctor